CLSI M45-A2

Methods for Antimicrobial Dilution and Disk Susceptibility Testing of Infrequently Isolated or Fastidious Bacteria; Approved Guideline-Second Edition, M45A2E

Clinical and Laboratory Standards Institute, 08/01/2010

Publisher: CLSI

File Format: PDF

$114.00$228.69

Description

Published:01/08/2010

Pages:100

This document provides guidance to clinical microbiology laboratories for standardized susceptibility testing of infrequently isolated or fastidious bacteria that are not presently included in CLSI documents M02 or M07. The tabular information in this document presents the most current information for drug selection, interpretation, and quality control for the infrequently isolated or fastidious bacterial pathogens included in this guideline.

More CLSI standard pdf

CLSI H3-A4

Procedure for the Collection of Diagnostic Blood Specimens by Venipuncture; Approved Standard

$136.00 $272.21

CLSI I03A

Standards for Relating Spectrophotometer Performance Characteristics to Analytical Goals; Approved Standard, I03-A

$90.00 $180.00

CLSI NBS04-A

Newborn Screening by Tandem Mass Spectrometry; Approved Guideline (formerly I/LA32-A), NBS04AE

$113.00 $227.62

CLSI NBS05-A

Newborn Screening for Cystic Fibrosis; Approved Guideline (Formerly I/LA35-A), NBS05AE

$90.00 $180.00